These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30651930)

  • 1. CD39
    Ahlmanner F; Sundström P; Akeus P; Eklöf J; Börjesson L; Gustavsson B; Lindskog EB; Raghavan S; Quiding-Järbrink M
    Oncotarget; 2018 Dec; 9(97):36993-37007. PubMed ID: 30651930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral regulatory T cells from colon cancer patients comprise several activated effector populations.
    Szeponik L; Ahlmanner F; Sundström P; Rodin W; Gustavsson B; Bexe Lindskog E; Wettergren Y; Quiding-Järbrink M
    BMC Immunol; 2021 Aug; 22(1):58. PubMed ID: 34407765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phenotypical and functional characteristic of FoxP3(+);CD39(+); regulatory T cells in humans].
    Huang HH; Wang SY; Wang HF; Fu JL; Han P; Wang FS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jun; 26(6):536-8. PubMed ID: 20487644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral FoxP3
    Syed Khaja AS; Toor SM; El Salhat H; Ali BR; Elkord E
    Front Immunol; 2017; 8():619. PubMed ID: 28603527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients.
    Jie HB; Gildener-Leapman N; Li J; Srivastava RM; Gibson SP; Whiteside TL; Ferris RL
    Br J Cancer; 2013 Nov; 109(10):2629-35. PubMed ID: 24169351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface expression of CD39 identifies an enriched Treg-cell subset in the rheumatic joint, which does not suppress IL-17A secretion.
    Herrath J; Chemin K; Albrecht I; Catrina AI; Malmström V
    Eur J Immunol; 2014 Oct; 44(10):2979-89. PubMed ID: 24990235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating gluten-specific FOXP3
    Cook L; Munier CML; Seddiki N; van Bockel D; Ontiveros N; Hardy MY; Gillies JK; Levings MK; Reid HH; Petersen J; Rossjohn J; Anderson RP; Zaunders JJ; Tye-Din JA; Kelleher AD
    J Allergy Clin Immunol; 2017 Dec; 140(6):1592-1603.e8. PubMed ID: 28283419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
    Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
    Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal photophoresis augments function of CD4+CD25+FoxP3+ regulatory T cells by triggering adenosine production.
    Schmitt S; Johnson TS; Karakhanova S; Näher H; Mahnke K; Enk AH
    Transplantation; 2009 Aug; 88(3):411-6. PubMed ID: 19667946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of CCR4⁺CTLA-4 FOXP3⁺CD25(hi) regulatory T cells in colon adenocarcinomas correlate to reduced activation of conventional T cells.
    Svensson H; Olofsson V; Lundin S; Yakkala C; Björck S; Börjesson L; Gustavsson B; Quiding-Järbrink M
    PLoS One; 2012; 7(2):e30695. PubMed ID: 22319577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.
    Syed Khaja AS; Toor SM; El Salhat H; Faour I; Ul Haq N; Ali BR; Elkord E
    Oncotarget; 2017 May; 8(20):33159-33171. PubMed ID: 28388539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T Cells from Colon Cancer Patients Inhibit Effector T-cell Migration through an Adenosine-Dependent Mechanism.
    Sundström P; Stenstad H; Langenes V; Ahlmanner F; Theander L; Ndah TG; Fredin K; Börjesson L; Gustavsson B; Bastid J; Quiding-Järbrink M
    Cancer Immunol Res; 2016 Mar; 4(3):183-93. PubMed ID: 26787824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. iTreg induced from CD39(+) naive T cells demonstrate enhanced proliferate and suppressive ability.
    Lu Y; Wang X; Gu J; Lu H; Zhang F; Li X; Qian X; Wang X; Lu L
    Int Immunopharmacol; 2015 Oct; 28(2):925-30. PubMed ID: 25864618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enrichment of Inflammatory IL-17 and TNF-α Secreting CD4(+) T Cells within Colorectal Tumors despite the Presence of Elevated CD39(+) T Regulatory Cells and Increased Expression of the Immune Checkpoint Molecule, PD-1.
    Dunne MR; Ryan C; Nolan B; Tosetto M; Geraghty R; Winter DC; O'Connell PR; Hyland JM; Doherty GA; Sheahan K; Ryan EJ; Fletcher JM
    Front Oncol; 2016; 6():50. PubMed ID: 27014625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo-expanded baboon CD39 +  regulatory T cells prevent rejection of porcine islet xenografts in NOD-SCID IL-2rγ
    Huang D; Wang Y; Hawthorne WJ; Hu M; Hawkes J; Burns H; Davies S; Gao F; Chew YV; Yi S; O'Connell PJ
    Xenotransplantation; 2017 Nov; 24(6):. PubMed ID: 28963731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased tumor-infiltrating CD45RA
    Mao FY; Kong H; Zhao YL; Peng LS; Chen W; Zhang JY; Cheng P; Wang TT; Lv YP; Teng YS; Fu XL; Liu YG; Wu XL; Hao CJ; You N; Luo P; Yu PW; Zou QM; Guo G; Zhuang Y
    Cell Death Dis; 2017 Aug; 8(8):e3002. PubMed ID: 28817117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Noninfectious Uveitis Using Intravenous Administration of Collagen II-Specific Type 1 Regulatory T Cells.
    Asnagli H; Jacquin M; Belmonte N; Gertner-Dardenne J; Hubert MF; Sales A; Fall PB; Ginet C; Marchetti I; Ménard F; Lara G; Bobak N; Foussat A
    Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6456-66. PubMed ID: 26447979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-infiltrating CD39
    Hu G; Wu P; Cheng P; Zhang Z; Wang Z; Yu X; Shao X; Wu D; Ye J; Zhang T; Wang X; Qiu F; Yan J; Huang J
    Oncoimmunology; 2017; 6(2):e1277305. PubMed ID: 28344891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of CD4
    McRae JL; Chia JS; Pommey SA; Dwyer KM
    Nephrology (Carlton); 2017 Jul; 22(7):505-512. PubMed ID: 27517975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.